Molinalogo

Measure

2023

Rate

2023

Goal

2024

Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

63.58%

64.90%

66.79%

66.15%

Annual Dental Visits (ADV) Total

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

42.63%

46.74%

39.09%

48.16%

Appropriate Testing for Pharyngitis (CWP)

65.69%

77.56%

77.62%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

91.42%

93.08%

89.75%

91.27%

Asthma Medication Ratio (AMR) Total

79.69%

69.41%

79.75%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

65.53%

66.19%

64.55%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

68.61%

68.61%

62.04%

71.78%

Breast Cancer Screening (BCS)

60.96%

55.25%

Breast Cancer Screening (BCS-E)

60.58%

54.94%

60.13%

56.66%

Cervical Cancer Screening (CCS)

64.72%

59.85%

62.04%

60.10%

Childhood Immunization Status (CIS) Combination #10

33.84%

35.04%

35.28%

31.32%

Chlamydia Screening in Women (CHL) Total

62.88%

61.07%

65.75%

61.46%

Controlling High Blood Pressure (CBP)

71.29%

65.45%

64.48%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

82.27%

80.86%

83.62%

83.51%

Eye Exam for Patients With Diabetes (EED)

49.15%

56.20%

48.91%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

19.64%

27.73%

12.14%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

30.95%

46.35%

37.50%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

31.99%

41.03%

32.51%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

18.46%

37.31%

24.07%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

62.34%

57.90%

61.54%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

61.54%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

53.53%

55.72%

49.39%

59.64%

Immunizations for Adolescents (IMA) Combination #2

43.07%

38.93%

40.88%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

7.54%

16.94%

7.44%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

43.76%

38.80%

46.99%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

34.67%

39.01%

39.90%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

39.90%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

10.07%

31.93%

6.33%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

59.35%

75.79%

63.48%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

83.74%

86.96%

80.87%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

101.87%

≤ 92.72%

92.32%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

86.37%

86.86%

80.05%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

78.10%

80.78%

76.89%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

8.19%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

8.19%

25.81%

9.91%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

1.95%

≤ 2.45%

2.01%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

81.46%

81.64%

82.43%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

54.48%

73.63%

62.70%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

70.16%

67.07%

70.79%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

49.10%

70.37%

56.69%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

77.50%

63.89%

70.94%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

64.30%

75.44%

64.61%

72.74%

Use of Opioids at High Dosage (HDO)

10.70%

≤ 2.19%

9.88%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

1.11%

≤ 0.87%

1.36%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

84.91%

83.21%

88.08%

86.20%